- Home
- / InflaRx
InflaRx
Stock Price
$1.6
2024-10-29
Market Capitalization
$92.2 M
2024-10-29
Revenue
€29 K
FY, 2025
InflaRx Summary
Company Summary
- Overview
- InflaRx is a biopharmaceutical company developing new therapeutics in the field of acute and chronic inflammation and consists of a team of internationally recognized researchers and clinicians who have dedicated their careers to translate discoveries and expertise into new therapeutic concepts for clinical application.
- Type
- Public
- Status
- Active
- Founded
- 2006
- HQ
- Jena, DE | view all locations
- Website
- https://www.inflarx.de/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
2 locations detected
Jena, TH HQ
Germany
Winzerlaer Str. 2
Planegg, BY
Germany
Fraunhoferstraße 22
InflaRx Financials
Summary Financials
- Gross profit (Q1, 2026)
- €248.0K
- Net income (Q1, 2026)
- (€5.6M)
- Cash (Q1, 2026)
- €15.0M
- EBIT (Q1, 2026)
- (€6.4M)
- Enterprise value
- $78.0M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026